The Patent Finder

Compositions Comprising Pharmaceutically Acceptable Salts of Glucagon-Like PEPTIDE-1 Analogs and Uses Thereof

I2O Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/US2022/049585, filed Nov 10, 2022. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,233,110Compositions Comprising Pharmaceutically Acceptable Salts of Glucagon-Like PEPTIDE-1 Analogs and Uses Thereof
In force
 · Medium confidence
UsedRemaining
I2O Therapeutics, Inc.In forceMedium confidence
US 12,233,111Compositions Comprising Pharmaceutically Acceptable Salts of Glucagon-Like PEPTIDE-1 Analogs and Uses Thereof
In force
 · Medium confidence
I2O Therapeutics, Inc.In forceMedium confidence
US 12,233,112Compositions Comprising Pharmaceutically Acceptable Salts of Amylin Analogs and Uses Thereof
In force
 · Medium confidence
I2O Therapeutics, Inc.In forceMedium confidence
US 12,337,029Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof
In force
 · Low confidence
I2O Therapeutics, Inc.In forceLow confidence
US 12,350,320Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and pharmaceutically acceptable salts of amylin analogs, and uses thereof
In force
 · Medium confidence
I2O Therapeutics, Inc.In forceMedium confidence
Application 18/946,213Compositions Comprising Therapeutic Proteins or Peptides, and Uses Thereof
Pending
Not granted
I2O Therapeutics, Inc.PendingNot granted
Application 18/960,864Method of Treating Disease or Disorder Using Compositions Comprising Pharmaceutically Acceptable Salts of Amylin Analogs
Pending
Not granted
I2O Therapeutics, Inc.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by I2O Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited